AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Is Biocon making a comeback?
Finshots Daily
Complex diseases, Biologics, and Biocon's biosimilars business
5min Snip
00:00
Summary
Transcript
Episode notes
This chapter explores the complex world of biologics and biosimilars, discussing Biocon's strategy in developing these complex proteins to treat diseases like cancer and diabetes. It also touches on the challenges faced by Biocon, such as delays in approvals and concerns about corporate governance.
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode